ETF Managers Group’s AdaptHealth AHCO Stock Holding History

ETF Managers Group’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-15,229	Closed	-$293K	–	688
2022 Q4	$293K	Buy	+15,229	New	+$322K	0.01%	438

Other funds holding AHCO

OCA

OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ETF Managers Group's AHCO Position: Q1 2023 in Review

ETF Managers Group sold out of AdaptHealth (AHCO) in Q1 2023, closing a stake of 15,229 shares — an estimated $293K sold.

ETF Managers Group first reported a position in AHCO in Q4 2022 and held it in 1 quarter. The position peaked at $293K in Q4 2022. 171 funds tracked by Wall St. Rank hold AHCO as of Q1 2023.

ETF Managers Group reported no remaining AdaptHealth position as of Q1 2023 after selling out during the quarter.
ETF Managers Group sold 15,229 AdaptHealth shares in Q1 2023, an estimated $293K.
ETF Managers Group first reported a position in AdaptHealth in Q4 2022 and held it in 1 quarter.
ETF Managers Group's AdaptHealth position peaked at $293K in Q4 2022.
171 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.